Compare SLN & TWNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.
Twin Hospitality Group Inc is a franchisor and operator of two dining restaurant concepts: Twin Peaks and Smokey Bones. Twin Peaks is an award-winning sports lodged themed restaurant chain known for its made-from-scratch food, draft beer, cocktail program and sports on wall-to-wall televisions at rugged lodge atmosphere themed restaurants. Smokey Bones is a full-service, meat-centric restaurant brand and concept specializing in award-winning ribs and a variety of other slow-smoked, fire-grilled or seared meats, along with a full bar featuring a wide selection of domestic, import and local craft beers, a variety of spirits and several signature handcrafted cocktails. It serves dine-in guests for lunch, dinner and late night and offers pick-up, delivery, online ordering.